Trial Profile
COG Erwinase Use for Acute Lymphoblastic Leukemia (ALL) Treatment Under IND 290.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2016
Price :
$35
*
At a glance
- Drugs Crisantaspase (Primary)
- Indications B-cell lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma; T-cell lymphoma
- Focus Adverse reactions; Expanded access; Therapeutic Use
- Acronyms EMTP
- 09 Jun 2010 New source identified and integrated (Vanderbilt-Ingram Cancer Center, VICCPED0711).
- 21 Apr 2009 New source identified and integrated (Barbara Ann Karmanos Cancer Institute).
- 21 Apr 2009 Additional lead trial investigator identified as reported by Barbara Ann Karmanos Cancer Institute.